AquaBounty Announced Plans to Cease Fish Farming Operations
On Dec. 11, 2024 the Board of Directors of AquaBounty Technologies announced that the Company was winding down…
Biotechnology | Disease | Life Science News | Medicine | Non-Profit Research | Ophthalmogy | Organ Transplant | Therapeutics
University of Colorado Anschutz Medical Campus-Led Team Receives Up to $46 Million to Develop Innovative Treatment to Cure Blindness
On Dec. 2, 2024, the University of Colorado Anschutz Medical Campus announced it will receive up to $46…
Lilly announced $4.5 billion investment in the Lilly Medicine Foundry – to drive innovation in drug production and medicines for clinical trials
On Oct. 2, 2024, Eli Lilly and Company announced a $4.5 billion investment to create the Lilly Medicine…
Purdue nameed new pediatric cancer research center for the late Tyler Trent
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
AquaBounty Announced a Pause to Ohio Farm Construction While It Evaluated Alternatives
On Jun. 22, 2023 AquaBounty Technologies announced that the Company will pause the construction of its farm in…
Purdue Center for Cancer Research renamed Purdue Institute for Cancer Research
On Jan. 6, 2023, the Purdue Center for Cancer Research announced it was changing its name to the…
USDA increased efforts to protect U.S. poultry and expanded wild bird surveillance for Avian influenza
On Feb. 11, 2022, the U.S. Department of Agricultureï¾’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced…
H5N1 highly pathogenic avian influenza (HPAI) Reported in indiana
On Feb. 9, 2022, the Indiana Department of Health confirmed that a case of H5N1 highly pathogenic avian…
USDA confirmed highly pathogenic avian influenza commercial turkey flock in Dubois County, Indiana
On Feb. 9, 2022, the U.S. Department of Agricultureï¾’s National Veterinary Services Laboratories confirmed the presence of highly…
DoD awarded contracts to purchase COVID-19 antigen OTC test kits in support of POTUS’ 500 million free at-home COVID-19 Tests
On Jan. 14, 2022, the U.S. Department of Defense, in coordination with the U.S. Department of Health and…
AquaBounty received approval for the sale of GE Atlantic Salmon in Brazil
On Jun. 1, 2021, AquaBounty Technologies announced the regulatory approval of the Company’s GE Atlantic salmon by Brazil’s…
AquaBounty sold out first commercial harvest of genetically engineered Atlantic Salmon from its Indiana farm
On May 10, 2021, AquaBounty Technologies announced that purchase orders had been received for the planned harvest of…
Moderna and Catalent announced long-term strategic collaboration for vial filling of COVID-19 vaccine
On Apr. 6, 2021, Moderna and Catalent announced the expansion of their strategic collaboration to dedicate a new…
Baxter and Moderna announced agreement for manufacturing of Moderna COVID-19 vaccine in the US
On Mar. 8, 2021, Baxter and Moderna announced that they had entered into an agreement for Baxter BioPharma…
INOVIO to develop DNA-encoded monoclonal antibody (dMAb) candidates to treat COVID-19
On Dec. 15, 2020, Inovio Pharma announced the company and a team of scientists from The Wistar Institute,…
AquaBounty announced Mayfield, Kentucky as location for planned 10,000 metric ton salmon farm
On Oct. 29, 2020, AquaBounty Technologies announced that it had identified Mayfield, Kentucky as the potential location for…
Successful first harvest provided roadmap for scaling secure, domestic source of farm-raised salmon
On Jun. 30, 2020, AquaBounty Technologies announced it had successfully commenced the commercial-scale harvest of conventional Atlantic salmon…
Moderna and Catalent announced collaboration for fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate
On Jun. 25, 2020 Moderna announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine…
University of British Columbia Professor Amanda Vincent was named the 2020 winner of the Indianapolis Prize
On May 12, 2020, University of British Columbia Professor Amanda Vincent, the first biologist to study seahorses in…
Catalent signs agreement with Johnson & Johnson to be US manufacturing partner for lead COVID-19 vaccine candidate
On Apr. 29, 2020, Catalent announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby…
Catalent Biologics completed $14 million commercial packaging expansion at its Bloomington, Indiana facility
On Apr. 23, 2020, Catalent announced the completion of its $14 million expansion to increase the biologics packaging…
Eli Lilly and Indiana State Department of Health partnered to accelerate COVID-19 testing using Lilly Research Laboratories
On Mar. 18, 2020, Eli Lilly announced its scientists were partnering with the Indiana State Department of Health…
AquAdvantage announced FDA approval of first U.S. facility for commercial production of AquAdvantage Salmon
On Apr. 27, 2018, AquaBounty Technologies announced that it had received approval from the U.S. Food and Drug…
AquaBounty’s AquAdvantage Salmon approved by Health Canada
On May 20, 2016, AquaBounty Technologies announced that Health Canada had concluded its review of the AquAdvantage Salmon…
The FDA approved AquaBounty Technologies’ application to sell the AquAdvantage genetically engineered salmon
On Nov. 19, 2015, AquaBounty Technologies announced the U.S. Food and Drug Administration (FDA) had approved the Company’s…
Whole-genome sequences of 16 different mosquito species published in Science
On Nov. 27, 2014, two papers were published in Science that announced the completion and preliminary analyses of…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
The first U.S. imported case of Middle East Respiratory Syndrome (MERS) was confirmed
On May 1, 2014, the first U.S. imported case of Middle East Respiratory Syndrome (MERS) was confirmed in…
Indiana Biosciences Research Institute reached $50 millionï¾ start-up funding goal
On Nov. 19, 2013, the Indiana Biosciences Research Institute (IBRI) was initially funded with $50 million provided by…
Fund raising began for the Indiana Biosciences Research Institute
On Nov. 19, 2013, the Indiana Biosciences Research Institute announced that it had reached the first $50 million…
The Indiana University Cancer Center renamed Indiana University Melvin and Bren Simon Cancer Center
In 2006, The Indiana University Cancer Center was renamed the Indiana University Melvin and Bren Simon Cancer Center….